CT-guided percutaneous permanent ~(125)I implantation for patients with malignant tumor
- VernacularTitle:CT导引下~(125)I粒子植入在治疗恶性肿瘤中的应用
- Author:
Zhenguo HUANG
;
Xuezhe ZHANG
;
Wu WANG
;
Xiaolin LUO
;
Jiying WANG
- Publication Type:Journal Article
- Keywords:
Neoplasms by site;
Iodine radioisotopes;
Radiology, interventional;
Brachytherapy
- From:
Chinese Journal of Radiology
2001;0(09):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the feasibility, safety, and efficacy of CT-guided permanent iodine-125 implantation for malignant tumors.Methods Thirteen lesions in 10 consecutive patients with malignant tumor were treated with CT-guided iodine-125 permanent implantation brachytherapy, of which four cases were primary unresectable carcinoma and six cases were metastases. There were 4 males and (6 females,) the mean age was 56.9 years (range 54 to 62 years). Based on the CT imaging within two weeks before the implantation of the seeds, a computer-based treatment planning system was used to determine the optimal seed distribution. Subsequent CT-guided needle placement and seed implantation were carried out. Post-implant CT scans were performed immediately and five to ten months after the implantation in all cases to assess seed distribution, complication, and curative effect. Results CT-guided iodine-125 permanent implantation was accomplished smoothly in all cases. This technique offered a better seed placement. The number of seeds implanted in one lesion was 1 to 44 (mean 18.6). No acute complications and late toxicity related to the implantation were observed. Pain relief was obtained in all four patients (100%) presenting with pain. Follow-up CT demonstrated that 3 of 13 lesions disappeared completely, eight lesions diminished, and the remaining 2 lesions had no significant change in size. Mean lesion size of pre-implant and post-implant were 3.15 cm and 2.06 cm, respectively (t=5.127, P
